0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Evidence-Based Dermatology: Research Commentary |

Validation of Psoriasis Clinical Severity and Outcome Measures Searching for a Gold Standard

J. Daniel Jensen, BS; Mayumi Fujita, MD, PhD; Robert P. Dellavalle, MD, PhD, MSPH
Arch Dermatol. 2011;147(1):95-98. doi:10.1001/archdermatol.2010.242.
Text Size: A A A
Published online

Extract

REFERENCES
Marks  RBarton  SPShuttleworth  DFinlay  AY Assessment of disease progress in psoriasis. Arch Dermatol 1989;125 (2) 235- 240
PubMed Link to Article[[XSLOpenURL/10.1001/archderm.1989.01670140087017]]
Ramsay  BLawrence  CM Measurement of involved surface area in patients with psoriasis. Br J Dermatol 1991;124 (6) 565- 570
PubMed Link to Article[[XSLOpenURL/10.1111/bjd.1991.124.issue-6]]
Yune  Y-MPark  SYOh  HS  et al.  Objective assessment of involved surface area in patients with psoriasis. Skin Res Technol 2003;9 (4) 339- 342
PubMed Link to Article[[XSLOpenURL/10.1034/j.1600-0846.2003.00042.x]]
Tiling-Grosse  SRees  J Assessment of area of involvement in skin disease: a study using schematic figure outlines. Br J Dermatol 1993;128 (1) 69- 74
PubMed Link to Article[[XSLOpenURL/10.1111/bjd.1993.128.issue-1]]
Savolainen  LKontinen  JAlatalo  ERöning  JOikarinen  A Comparison of actual psoriasis surface area and the psoriasis area and severity index by the human eye and machine vision methods in following the treatment of psoriasis. Acta Derm Venereol 1998;78 (6) 466- 467
PubMed Link to Article[[XSLOpenURL/10.1080/000155598442818]]
Savolainen  LKontinen  JRöning  JOikarinen  A Application of machine vision to assess involved surface in patients with psoriasis. Br J Dermatol 1997;137 (3) 395- 400
PubMed Link to Article[[XSLOpenURL/10.1111/j.1365-2133.1997.tb03745.x]]
Kreft  SKreft  MResman  AMarko  PKreft  KZ Computer-aided measurement of psoriatic lesion area in a multicenter clinical trial—comparison to physician's estimations. J Dermatol Sci 2006;44 (1) 21- 27
PubMed Link to Article[[XSLOpenURL/10.1016/j.jdermsci.2006.05.006]]
Ormerod  ADDwyer  CMWeller  RCox  DHPrice  R A comparison of subjective and objective measures of reduction of psoriasis with the use of ultrasound, reflectance colorimetry, computerized video image analysis, and nitric oxide production. J Am Acad Dermatol 1997;37 (1) 51- 57
PubMed Link to Article[[XSLOpenURL/10.1016/S0190-9622(97)70211-1]]
Langley  RGEllis  CN Evaluating psoriasis with psoriasis area and severity index, psoriasis global assessment, and lattice system physician's global assessment. J Am Acad Dermatol 2004;51 (4) 563- 569
PubMed Link to Article[[XSLOpenURL/10.1016/j.jaad.2004.04.012]]
Gottlieb  ABChaudhari  UBaker  DGPerate  MDooley  LT The National Psoriasis Foundation Psoriasis Score (NPF-PS) system versus the Psoriasis Area Severity Index (PASI) and Physician's Global Assessment (PGA): a comparison. J Drugs Dermatol 2003;2 (3) 260- 266
PubMed
Rakkhit  TPanko  JMChristensen  TE  et al.  Plaque thickness and morphology in psoriasis vulgaris associated with therapeutic response. Br J Dermatol 2009;160 (5) 1083- 1089
PubMed Link to Article[[XSLOpenURL/10.1111/bjd.2009.160.issue-5]]
Serup  JAgner  T Colorimetric quantification of erythema—a comparison of two colorimeters (Lange Micro Color and Minolta Chroma Meter CR-200) with a clinical scoring scheme and laser-Doppler flowmetry. Clin Exp Dermatol 1990;15 (4) 267- 272
PubMed Link to Article[[XSLOpenURL/10.1111/ced.1990.15.issue-4]]
Lahti  AKopola  HHarila  AMyllylä  RHannuksela  M Assessment of skin erythema by eye, laser Doppler flowmeter, spectroradiometer, two-channel erythema meter and Minolta chroma meter. Arch Dermatol Res 1993;285 (5) 278- 282
PubMed Link to Article[[XSLOpenURL/10.1007/BF00371596]]
Harari  MShani  JHristakieva  EStanimirovic  ASeidl  WBurdo  A Clinical evaluation of a more rapid and sensitive Psoriasis Assessment Severity Score (PASS), and its comparison with the classic method of Psoriasis Area and Severity Index (PASI), before and after climatotherapy at the Dead-Sea. Int J Dermatol 2000;39 (12) 913- 918
PubMed Link to Article[[XSLOpenURL/10.1046/j.1365-4362.2000.00017.x]]
Jacobson  CCKimball  AB Rethinking the Psoriasis Area and Severity Index: the impact of area should be increased. Br J Dermatol 2004;151 (2) 381- 387
PubMed Link to Article[[XSLOpenURL/10.1111/bjd.2004.151.issue-2]]
Berth-Jones  JGrotzinger  KRainville  C  et al.  A study examining inter- and intrarater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global Assessment. Br J Dermatol 2006;155 (4) 707- 713
PubMed Link to Article[[XSLOpenURL/10.1111/bjd.2006.155.issue-4]]
Kirby  BFortune  DGBhushan  MChalmers  RJGriffiths  CE The Salford Psoriasis Index: an holistic measure of psoriasis severity. Br J Dermatol 2000;142 (4) 728- 732
PubMed Link to Article[[XSLOpenURL/10.1046/j.1365-2133.2000.03418.x]]
Sampogna  FSera  FAbeni  DIDI Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) Investigators, Measures of clinical severity, quality of life, and psychological distress in patients with psoriasis: a cluster analysis. J Invest Dermatol 2004;122 (3) 602- 607
PubMed Link to Article[[XSLOpenURL/10.1046/j.0022-202X.2003.09101.x]]
Feldman  SRFleischer  AB  JrReboussin  DM  et al.  The self-administered psoriasis area and severity index is valid and reliable. J Invest Dermatol 1996;106 (1) 183- 186
PubMed Link to Article[[XSLOpenURL/10.1111/jid.1996.106.issue-1]]
Szepietowski  JCSikora  MPacholek  T  et al.  Clinical evaluation of the self-administered psoriasis area and severity index (SAPASI). Acta Dermatovenerol Alp Panonica Adriat 2001;10 (3) 79- 83
Sampogna  FSera  FMazzotti  EPasquini  PPicardi  AAbeni  DIDI Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) Study Group, Performance of the self-administered psoriasis area and severity index in evaluating clinical and sociodemographic subgroups of patients with psoriasis. Arch Dermatol 2003;139 (3) 353- 358
PubMed Link to Article[[XSLOpenURL/10.1001/archderm.139.3.353]]
Louden  BAPearce  DJLang  WFeldman  SR A Simplified Psoriasis Area Severity Index (SPASI) for rating psoriasis severity in clinic patients. Dermatol Online J 2004;10 (2) 7
PubMed
Figures in this Article

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview

Figures

Place holder to copy figure label and caption
Figure.

A male adult with plaque psoriasis before (A) and after (B) 12 weeks of therapy with etanercept.

Graphic Jump Location

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

204 Views
6 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Jobs
brightcove.createExperiences();